These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23709368)

  • 41. Gene knockout of tau expression does not contribute to the pathogenesis of prion disease.
    Lawson VA; Klemm HM; Welton JM; Masters CL; Crouch P; Cappai R; Ciccotosto GD
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):1036-45. PubMed ID: 22002429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibril formation of the rabbit/human/bovine prion proteins.
    Zhou Z; Yan X; Pan K; Chen J; Xie ZS; Xiao GF; Yang FQ; Liang Y
    Biophys J; 2011 Sep; 101(6):1483-92. PubMed ID: 21943430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.
    Duyckaerts C; Seilhean D; Sazdovitch V; Plu I; Delatour B; Potier MC
    Bull Acad Natl Med; 2015 Jun; 199(6):809-819. PubMed ID: 29901881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Redox mechanisms and their pathological role in prion diseases: The road to ruin.
    Spiers JG; Chen HC; Steinert JR
    PLoS Pathog; 2023 Apr; 19(4):e1011309. PubMed ID: 37104170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-molecule approaches to prion protein misfolding.
    Yu H; Dee DR; Woodside MT
    Prion; 2013; 7(2):140-6. PubMed ID: 23357831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transgenetic investigations of prion diseases of humans and animals.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
    Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
    Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of molecular target based-therapy for prion diseases].
    Sakasegawa Y; Doh-ura K
    Brain Nerve; 2007 Apr; 59(4):405-14. PubMed ID: 17447527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prionoses--neurodegenerative diseases caused by prions, offectious proteinaceous molecules].
    Ferencík M; Novák M; Mikula I; Sokol J
    Bratisl Lek Listy; 1998; 99(8-9):486-98. PubMed ID: 9810774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prions and prion diseases: fundamentals and mechanistic details.
    Ryou C
    J Microbiol Biotechnol; 2007 Jul; 17(7):1059-70. PubMed ID: 18051314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reconstructing prions: fibril assembly from simple yeast to complex mammals.
    Sigurdson C; Polymenidou M; Aguzzi A
    Neurodegener Dis; 2005; 2(1):1-5. PubMed ID: 16908997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prion protein oligomer and its neurotoxicity.
    Huang P; Lian F; Wen Y; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The "Jekyll and Hyde" Actions of Nucleic Acids on the Prion-like Aggregation of Proteins.
    Silva JL; Cordeiro Y
    J Biol Chem; 2016 Jul; 291(30):15482-90. PubMed ID: 27288413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional Prions in the Brain.
    Rayman JB; Kandel ER
    Cold Spring Harb Perspect Biol; 2017 Jan; 9(1):. PubMed ID: 28049644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding.
    Zhou Z; Fan JB; Zhu HL; Shewmaker F; Yan X; Chen X; Chen J; Xiao GF; Guo L; Liang Y
    J Biol Chem; 2009 Oct; 284(44):30148-58. PubMed ID: 19748895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transmissible amyloid.
    Tjernberg LO; Rising A; Johansson J; Jaudzems K; Westermark P
    J Intern Med; 2016 Aug; 280(2):153-63. PubMed ID: 27002185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo generation of prion strains.
    Colby DW; Prusiner SB
    Nat Rev Microbiol; 2011 Sep; 9(11):771-7. PubMed ID: 21947062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.